Vanguard Group Inc Nexalin Technology, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Nexalin Technology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 31,780 shares of NXL stock, worth $121,399. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,780
Previous 31,780
-0.0%
Holding current value
$121,399
Previous $53,000
60.38%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NXL
# of Institutions
17Shares Held
484KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny103KShares$393,0780.0% of portfolio
-
Geode Capital Management, LLC Boston, MA78.7KShares$300,6220.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il58.2KShares$222,2660.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE55.5KShares$211,8640.81% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA42.4KShares$161,9030.0% of portfolio
About Nexalin Technology, Inc.
- Ticker NXL
- Exchange
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 7,279,960
- Market Cap $27.8M